IT1178911B - Dispositivo osmotico avente duplice attivita termodinamica per la erogazione a velocita controllata di una sostanza particolarmente un farmaco all ambiente a cui e destinata - Google Patents
Dispositivo osmotico avente duplice attivita termodinamica per la erogazione a velocita controllata di una sostanza particolarmente un farmaco all ambiente a cui e destinataInfo
- Publication number
- IT1178911B IT1178911B IT8467283A IT6728384A IT1178911B IT 1178911 B IT1178911 B IT 1178911B IT 8467283 A IT8467283 A IT 8467283A IT 6728384 A IT6728384 A IT 6728384A IT 1178911 B IT1178911 B IT 1178911B
- Authority
- IT
- Italy
- Prior art keywords
- drug
- substance
- environment
- intended
- controlled speed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- External Artificial Organs (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49376083A | 1983-05-11 | 1983-05-11 |
Publications (3)
Publication Number | Publication Date |
---|---|
IT8467283A0 IT8467283A0 (it) | 1984-03-23 |
IT8467283A1 IT8467283A1 (it) | 1985-09-23 |
IT1178911B true IT1178911B (it) | 1987-09-16 |
Family
ID=23961585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT8467283A IT1178911B (it) | 1983-05-11 | 1984-03-23 | Dispositivo osmotico avente duplice attivita termodinamica per la erogazione a velocita controllata di una sostanza particolarmente un farmaco all ambiente a cui e destinata |
Country Status (20)
Country | Link |
---|---|
JP (1) | JPS6041609A (fr) |
AT (1) | AT397180B (fr) |
AU (1) | AU566110B2 (fr) |
BE (1) | BE898819A (fr) |
CA (1) | CA1222950A (fr) |
CH (1) | CH669329A5 (fr) |
DE (1) | DE3417113A1 (fr) |
DK (1) | DK163910C (fr) |
ES (1) | ES532018A0 (fr) |
FR (1) | FR2545721B1 (fr) |
GB (1) | GB2140687B (fr) |
IE (1) | IE56515B1 (fr) |
IL (1) | IL71727A (fr) |
IT (1) | IT1178911B (fr) |
MX (1) | MX163518B (fr) |
NL (1) | NL192250C (fr) |
NO (1) | NO170834C (fr) |
NZ (1) | NZ206600A (fr) |
SE (1) | SE455918B (fr) |
ZA (1) | ZA842422B (fr) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH075457B2 (ja) * | 1983-08-16 | 1995-01-25 | ザ ウエルカム フアウンデ−シヨン リミテツド | 調節された方法による有効成分の放出を可能にする医薬組成物 |
US4600773A (en) * | 1983-12-01 | 1986-07-15 | Eli Lilly And Company | Crystalline cephalexin hydrochloride monohydrate |
US4624847A (en) * | 1985-04-22 | 1986-11-25 | Alza Corporation | Drug delivery device for programmed delivery of beneficial drug |
US4704118A (en) * | 1985-08-16 | 1987-11-03 | Alza Corporation | Ruminant dispensing device with thermo-activated memory |
ES8800043A1 (es) * | 1985-08-16 | 1987-10-16 | Alza Corp | Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso |
US4963141A (en) * | 1985-08-16 | 1990-10-16 | Alza Corporation | Dispensing system for administering beneficial agent formulation to ruminants |
US4723957A (en) * | 1986-02-07 | 1988-02-09 | Alza Corp. | System for delivering drug with enhanced bioacceptability |
US4716496A (en) * | 1986-05-09 | 1987-12-29 | Eaton Corporation | Panel-mounted control station housing |
US4814181A (en) * | 1987-09-03 | 1989-03-21 | Alza Corporation | Dosage form comprising fast agent delivery followed by slow agent delivery |
US4816263A (en) * | 1987-10-02 | 1989-03-28 | Alza Corporation | Dosage form for treating cardiovascular diseases comprising isradipine |
EP0317780B1 (fr) * | 1987-11-25 | 1992-05-20 | American Cyanamid Company | Système de délivrance retardée (contrôlée) de dihydropyridine antagonistes de calcium substitués |
US4837111A (en) * | 1988-03-21 | 1989-06-06 | Alza Corporation | Dosage form for dispensing drug for human therapy |
US4855141A (en) * | 1988-03-25 | 1989-08-08 | Alza Corporation | Device comprising means for protecting and dispensing fluid sensitive medicament |
US4859470A (en) * | 1988-06-02 | 1989-08-22 | Alza Corporation | Dosage form for delivering diltiazem |
IL91398A (en) * | 1988-08-30 | 1994-05-30 | Pfizer | A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane |
US5612059A (en) * | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
GR1000270B (el) * | 1988-09-30 | 1992-05-12 | Alza Corp | Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων. |
IL92966A (en) * | 1989-01-12 | 1995-07-31 | Pfizer | Hydrogel-operated release devices |
US5030452A (en) * | 1989-01-12 | 1991-07-09 | Pfizer Inc. | Dispensing devices powered by lyotropic liquid crystals |
US5108756A (en) * | 1989-01-12 | 1992-04-28 | Pfizer Inc. | Dispensing devices powered by lyotropic liquid crystals |
EP0408496A3 (en) * | 1989-07-12 | 1992-07-01 | Ciba-Geigy Ag | Solid dosage form for pharmaceutical substances |
US5000962A (en) * | 1989-08-25 | 1991-03-19 | Schering Corporation | Long acting diltiazem formulation |
US4992277A (en) * | 1989-08-25 | 1991-02-12 | Schering Corporation | Immediate release diltiazem formulation |
US5067960A (en) * | 1989-12-06 | 1991-11-26 | Medtronic, Inc. | Muscle fitness detection by colorimetry |
US5190763A (en) * | 1990-05-07 | 1993-03-02 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
US5081161A (en) * | 1990-06-15 | 1992-01-14 | E. I. Du Pont De Nemours And Company | Process for making shaped articles of a thermoplastic resin having a microcellular structure |
NZ238867A (en) * | 1990-07-12 | 1993-08-26 | Alza Corp | Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device |
ES2067957T3 (es) * | 1990-08-07 | 1995-04-01 | Pfizer | Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion. |
US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
ES2053339T3 (es) * | 1990-09-28 | 1994-07-16 | Pfizer | Dispositivo dispensador conteniendo un medio hidrofobo. |
US5208037A (en) * | 1991-04-22 | 1993-05-04 | Alza Corporation | Dosage forms comprising polymers comprising different molecular weights |
ATE200221T1 (de) * | 1993-02-23 | 2001-04-15 | Wolfgang Dr Werner | Die verwendung eines calciumpräparates in einem medikament zur behandlung von an hypocalcämie leidenden milchkühen |
US6440457B1 (en) | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
US6287598B1 (en) * | 1993-05-28 | 2001-09-11 | Alza Corporation | Method for providing sustained antiepileptic therapy |
HU213407B (en) * | 1993-12-09 | 1997-06-30 | Egyt Gyogyszervegyeszeti Gyar | Process for producing tablet with diffusive-osmotic release |
US5460826A (en) * | 1994-06-27 | 1995-10-24 | Alza Corporation | Morphine therapy |
US5948787A (en) * | 1997-02-28 | 1999-09-07 | Alza Corporation | Compositions containing opiate analgesics |
DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
MXPA03003895A (es) * | 2000-10-30 | 2003-07-28 | Euro Celtique Sa | Formulaciones de hidrocodona de liberacion controlada. |
US20110104214A1 (en) | 2004-04-15 | 2011-05-05 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
DE10129725A1 (de) | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
DE10300111A1 (de) | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
US10213387B2 (en) | 2003-09-19 | 2019-02-26 | Sun Pharma Advanced Research Company Ltd. | Oral drug delivery system |
PL1663175T3 (pl) * | 2003-09-19 | 2012-09-28 | Sun Pharma Advanced Res Co Ltd | Doustny system podawania leku |
US10226428B2 (en) | 2003-09-19 | 2019-03-12 | Sun Pharma Advanced Research Company Ltd. | Oral drug delivery system |
DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
EP1685841A1 (fr) | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention et traitement de troubles thromboemboliques |
DE102005031577A1 (de) * | 2005-07-06 | 2007-01-11 | Bayer Healthcare Ag | Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten |
DE102005045518A1 (de) | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
PL1934208T3 (pl) | 2005-10-04 | 2011-09-30 | Bayer Ip Gmbh | Nowa polimorficzna postać 5-chloro-N-({ (5S)-2-okso-3-[4-( 3-okso-4-morfolinylo)-fenylo]-1,3-oksazolidyn-5-ylo}-metylo)-2-tiofenokarboksamidu |
DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
DE102008059206A1 (de) | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum |
US8956654B2 (en) * | 2009-06-02 | 2015-02-17 | Dow Global Technologies Llc | Sustained release dosage form |
DE102011007272A1 (de) | 2011-04-13 | 2012-10-18 | Bayer Pharma Aktiengesellschaft | Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung |
MX2014013320A (es) | 2012-05-07 | 2015-08-10 | Bayer Pharma AG | Procedimiento de fabricacion de una forma de dosificacion farmaceutica que comprende nifedipina y candesartan cilexetilo. |
UY34856A (es) | 2012-07-03 | 2013-12-31 | Bayer Pharma AG | Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida |
JP5941117B2 (ja) * | 2014-10-17 | 2016-06-29 | ダウ グローバル テクノロジーズ エルエルシー | 徐放製剤 |
MX2021000904A (es) | 2018-07-24 | 2021-03-31 | Bayer Ag | Forma de dosificacion farmaceutica administrable por via oral con liberacion modificada. |
EP3826619A1 (fr) | 2018-07-24 | 2021-06-02 | Bayer Aktiengesellschaft | Formes galéniques pharmaceutiques à libération modifiée à administrer par voie orale |
US10905667B2 (en) | 2018-07-24 | 2021-02-02 | Bayer Pharma Aktiengesellschaft | Orally administrable modified-release pharmaceutical dosage form |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL38538A (en) * | 1971-01-13 | 1974-09-10 | Alza Corp | Osmotic dispenser |
US3977404A (en) * | 1975-09-08 | 1976-08-31 | Alza Corporation | Osmotic device having microporous reservoir |
US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
US4160452A (en) * | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4449983A (en) * | 1982-03-22 | 1984-05-22 | Alza Corporation | Simultaneous delivery of two drugs from unit delivery device |
-
1983
- 1983-12-16 NZ NZ206600A patent/NZ206600A/en unknown
- 1983-12-19 AU AU22511/83A patent/AU566110B2/en not_active Expired
- 1983-12-22 GB GB08334189A patent/GB2140687B/en not_active Expired
-
1984
- 1984-01-05 IE IE10/84A patent/IE56515B1/en not_active IP Right Cessation
- 1984-01-24 NO NO840248A patent/NO170834C/no not_active IP Right Cessation
- 1984-02-02 BE BE0/212326A patent/BE898819A/fr not_active IP Right Cessation
- 1984-02-13 JP JP59024947A patent/JPS6041609A/ja active Granted
- 1984-02-24 DK DK099784A patent/DK163910C/da not_active IP Right Cessation
- 1984-02-29 MX MX200502A patent/MX163518B/es unknown
- 1984-03-15 AT AT0088084A patent/AT397180B/de not_active IP Right Cessation
- 1984-03-23 IT IT8467283A patent/IT1178911B/it active
- 1984-03-30 ZA ZA842422A patent/ZA842422B/xx unknown
- 1984-04-05 FR FR8405362A patent/FR2545721B1/fr not_active Expired
- 1984-04-27 ES ES532018A patent/ES532018A0/es active Granted
- 1984-05-02 IL IL71727A patent/IL71727A/xx not_active IP Right Cessation
- 1984-05-08 NL NL8401470A patent/NL192250C/nl not_active IP Right Cessation
- 1984-05-09 SE SE8402512A patent/SE455918B/sv not_active IP Right Cessation
- 1984-05-09 DE DE3417113A patent/DE3417113A1/de active Granted
- 1984-05-10 CA CA000453998A patent/CA1222950A/fr not_active Expired
- 1984-05-10 CH CH2309/84A patent/CH669329A5/de not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1178911B (it) | Dispositivo osmotico avente duplice attivita termodinamica per la erogazione a velocita controllata di una sostanza particolarmente un farmaco all ambiente a cui e destinata | |
ES549639A0 (es) | Dispositivo osmotico para la administracion controlada de unagente benefico a un ambiente de utilizacion | |
IT8322832A0 (it) | Dispositivo per la somministrazione controllata di farmaci. | |
IT8267184A0 (it) | Bendaggio per la somministrazione di medicamenti | |
IT1128094B (it) | Catetere per la somministrazione en dovenosa intermittente di medicamenti | |
IT1188095B (it) | Dispositivo osmotico comprendente mezzi per regolare la durata iniziale di erogazione di un agente medicinali da detto dispositivo | |
DK253988D0 (da) | Farmaceutisk praeparat med indhold af eperison eller tolperison, eller et salt deraf, til indgivelse gennem huden | |
NL195004B (nl) | Fenylcarbamaat bevattend farmaceutisch preparaat. | |
DE68914344D1 (de) | Immununterdrückende Verbindungen. | |
DE3685170D1 (de) | Histaminderivate enthaltende pharmazeutische zusammensetzung. | |
DE3480599D1 (de) | 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen. | |
DE3485408D1 (de) | Pharmazeutische zusammensetzung. | |
ES552145A0 (es) | Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico. | |
DK166479C (da) | Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning | |
IT1190824B (it) | Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo | |
IT8319857A0 (it) | Agenti antiflogistici/antipiretici/analgesici contenenti derivati di teobromina o teofillina come ingrediente attivo. | |
NO881558D0 (no) | Oppvarmer for vaeske som stroemmer som fallende film. | |
SE404800B (sv) | Vissa angivna tetrahydro-1,3,5-triazin-2,6-dioner till anvendning som herbicider | |
IT1179843B (it) | Dispositivo osmotico e procedimento per l erogazione di un agente benefico particolarmente di un farmaco ad un ambiente d uso | |
IT1213080B (it) | Sistemi terapeutico per la cessione controllata di farmaci. | |
IT8421874A0 (it) | Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno. | |
IT7822316A0 (it) | Composizione farmaceutica per la somministrazione di pancreatina. | |
DK162631C (da) | Forbindelse, betegnet fr-900216, til anvendelse som terapeutisk aktivt stof, farmaceutisk praeparat indeholdende forbindelsen samt anvendelse af forbindelsen | |
IT8149298A0 (it) | Tampone per la somministrazione di nitroglicerina attraverso la pelle | |
FI823470L (fi) | Nya cykliska iminer, deras tillverkning och farmaceutiska kompositioner innehaollande dessa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19980327 |